Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Octreotide Acetate Injection, a Somatostatin Analog, in five vial presentations. According to IMS, for the 12 months ending October 2013, the US market for Octreotide ...
US-based Sagent Pharmaceuticals has introduced propofol injectable emulsion USP 1%, in two single-dose, single-patient vial presentations of 20mL and 100mL. The company said that a 50mL single-dose, single-patient vial presentation will ...
US-based Sagent Pharmaceuticals has introduced an antineoplastic agent ' Doxorubicin Hydrochloride Injection' in three vial presentations. The injection has been used to produce regression in disseminated neoplastic conditions like acute ...
US-based Sagent Pharmaceuticals (SGNT) has introduced an antineoplastic agent 'Carboplatin Injection' in four preservative-free vial presentations. The injection is indicated for the initial treatment of advanced ovarian carcinoma in ...
Sagent Pharmaceuticals has re-introduced an antiarrhythmic agent Amiodarone HCl Injection as an improved prefilled plastic syringe compatible with standard I.V. pumps. Featuring Sagent's PreventIV Measures packaging and labeling to help ...
Tags: HCL Injection, Health
Specialty pharmaceutical company Sagent Pharmaceuticals has introduced an antineoplastic agent, Docetaxel Injection Concentrate, in three preservative-free vial presentations. Designed to help reduce medication errors, the product ...
Tags: Sagent, Medicine errors
Sagent Pharmaceuticals has signed an agreement to acquire 50% interest of its joint venture (JV) partner, Chengdu Kanghong Pharmaceuticals, in the Kanghong Sagent Pharmaceutical (KSPC) JV, for $25m. KSCP will become a wholly-owned ...
Tags: Sagent Pharmaceuticals, Medicine
Specialty pharmaceutical company Sagent Pharmaceuticals has opted for Elsevier's Gold Standard's drug information technologies, ProspectoRx and Clinical Pharmacology to access current and accurate drug data and pricing. ProspectorRx ...
Sagent Pharmaceuticals has announced the temporary importation of 8.4% Sodium Bicarbonate Injection, USP into the US market from Australia-based Phebra. The temporary arrangement is to address the present critical shortage of non-FDA ...
Tags: Sagent, Sodium Bicarbonate Injection, drug, drug shortage
Sagent Pharmaceuticals has introduced Flumazenil Injection, USP, available in two latex-free vials featuring the PreventIV Measures packaging and labeling. The benzodiazepine antagonist is indicated for the complete or partial reversal of ...
Tags: Sagent Pharmaceuticals, Flumazenil Injection, USP, PreventIV
Sagent Pharmaceuticals has launched Nafcillin for Injection, USP in two vial presentations and one pharmacy bulk package bottle, which are preservative-free and latex-free. Nafcillin had hit nearly $62m sales for 12 months ending ...
Tags: Nafcillin, injection, Sagent Pharmaceuticals, suspected cases
Sagent Pharmaceuticals has introduced Acetazolamide for Injection, USP specified for adjunctive treatment of edema due to congestive heart failure, drug-induced edema, centrencephalic epilepsies and chronic simple glaucoma, secondary ...
Tags: Acetazolamide Injection, adjunctive treatment, Pharmaceuticals
Sagent Pharmaceuticals, a specialty pharmaceutical company, has introduced Irinotecan injection in two latex free, preservative free single dose vials. The antineoplastic agent of the topoisomerase I inhibitor class, in combination with ...
Sagent Pharmaceuticals has introduced a folic acid derivative therapy, designed to treat megaloblastic anemias patients who are not responding to oral therapy. The new Leucovorin Calcium for Injection is indicated for rescue after ...
Sagent Pharmaceuticals,a specialty pharmaceutical company,has launched Ondansetron Injection,USP,an antiemetic,in two latex-free vial presentations. Ondansetron Injection,USP is indicated for prevention of nausea and vomiting associated ...